Pages that link to "Category:CS1 maint: Explicit use of et al."
From Self-sufficiency
The following pages link to Category:CS1 maint: Explicit use of et al.:
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Targeted therapy (← links)
- Selective androgen receptor modulator (← links)
- Eltrombopag (← links)
- Venlafaxine (← links)
- Drug overdose (← links)
- Number needed to treat (← links)
- Functional selectivity (← links)
- HERG (← links)
- PDE5 drug design (← links)
- Leukemia inhibitory factor (← links)
- PPAR modulator (← links)
- Benzodiazepine (← links)
- Drug discovery (← links)
- Randomized controlled trial (← links)
- Rebound effect (← links)
- Benzodiazepine dependence (← links)
- Use of biotechnology in pharmaceutical manufacturing (← links)
- Benzodiazepine withdrawal syndrome (← links)
- Long-term effects of benzodiazepines (← links)
- Receptor antagonist (← links)
- Serotonin syndrome (← links)
- List of drugs affected by grapefruit (← links)
- Burow's solution (← links)
- LiPE (← links)
- Criticism of the Food and Drug Administration (← links)
- Dopexamine (← links)
- Mephedrone (← links)
- Semaxanib (← links)
- Safrazine (← links)
- Ladostigil (← links)
- Metapramine (← links)
- Pardoprunox (← links)
- SL65.0155 (← links)
- Fluotracen (← links)
- Xanomeline (← links)
- Dimethyltryptamine (← links)
- Salvinorin A (← links)
- Tetrahydrocannabivarin (← links)
- Cocaethylene (← links)
- Theanine (← links)
- Bretazenil (← links)
- Pagoclone (← links)
- Vanoxerine (← links)
- Oleoyl-estrone (← links)
- Ormeloxifene (← links)
- Ampligen (← links)
- Emodepside (← links)
- Artelinic acid (← links)
- Tafenoquine (← links)
- Talizumab (← links)